Related Experiment Video

Updated: Jan 10, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.2K

Pharmacological and Interventional Prevention and Treatment of Microvascular Obstruction Following Primary PCI in

Giovanni Occhipinti1, Michele Strosio2, Riccardo Rinaldi1

  • 1Cardiology Department, Cardiovascular Clinic Institute, Hospital Clínic de Barcelona, University of Barcelona, 08193 Barcelona, Spain.

Journal of Cardiovascular Development and Disease
|November 26, 2025
PubMed

Insights

Microvascular obstruction (MVO) affects up to 50% of ST-elevation myocardial infarction (STEMI) patients post-primary percutaneous coronary intervention (PCI). This review explores current pharmacological and interventional strategies to manage MVO and improve patient outcomes.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Interventional Cardiology

Background:

  • Microvascular obstruction (MVO) is a significant complication in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI), affecting up to 50% of cases.
  • The multifactorial pathogenesis involves myocardial ischemia, distal embolization, and ischemia-reperfusion injury, contributing to adverse clinical outcomes.
  • Current evidence for effective pharmacological or interventional strategies against MVO remains inconclusive.

Purpose of the Study:

  • To review and discuss current pharmacological and interventional approaches for managing microvascular obstruction (MVO) in STEMI patients.
  • To highlight the challenges and limitations in existing research, including study design variability and outdated reperfusion strategies.
  • To provide an overview of potential therapeutic avenues in the context of contemporary standards of care.

Main Methods:

  • Systematic literature review of pharmacological and interventional strategies for MVO.
  • Analysis of studies focusing on pathogenesis, clinical outcomes, and treatment efficacy.
  • Comparison of historical and current reperfusion strategies and drug therapies.

Main Results:

  • No single pharmacological or interventional strategy has demonstrated consistent effectiveness in preventing or treating MVO.
  • Significant heterogeneity in study designs, drug dosages, and reperfusion techniques complicates evidence interpretation.
  • Existing research often relies on outdated methodologies and standards of care.

Conclusions:

  • The management of MVO in STEMI patients remains a significant clinical challenge.
  • Further research with standardized methodologies and contemporary treatment protocols is crucial.
  • A comprehensive approach addressing the multifactorial nature of MVO is needed to improve patient outcomes.

Keywords:
MVOPCISTEMIcoronary no-Reflowmicrovascular obstruction

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.7K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

510

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
229
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
203
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
206
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
222
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
224
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301